InsiderTrades

Form 4 for ABT Abbott Laboratories

Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-03 · accession 0001415889-21-004285 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-08 2021-09-03 ABT WOODGRIFT RANDEL WILLIAM SVP M - OptEx $38.40 +1,000 50.1K +2% +$38.4K
DM 2021-09-08 2021-09-03 ABT WOODGRIFT RANDEL WILLIAM SVP S - Sale+OE $129.00 -6,350 49.1K -11% -$819.1K
D 2021-09-08 2021-09-03 ABT WOODGRIFT RANDEL WILLIAM SVP M - OptEx $0.00 -1,000 1,333 -43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common shares without par value 2021-09-03 M A 1,000 $38.40 50,093 D — —
2 Common Common shares without par value 2021-09-03 S D 5,350 $129.00 43,743 D — —
3 Common Common shares without par value 2021-09-03 S D 1,000 $129.00 49,093 D — —
4 Derivative Option (right to buy) 2021-09-03 M D 1,000 $0.00 1,333 D $38.40 · 2019-02-19 to 2026-02-18 1,000 Common Shares (F2) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.